CVS Health Corporation (CVS) Financial Statements

CVS Health Corporation

CVS · NYSE

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Total Revenue	$402.07B	$372.81B	$357.78B	$322.47B	$292.11B	$268.71B	$256.78B	$193.92B
Cost of Revenue	$221.17B	$206.29B	$217.10B	$196.89B	$175.80B	$163.98B	$158.72B	$156.45B
Operating Expenses	$397.41B	$364.29B	$344.03B	$314.51B	$278.80B	$254.79B	$33.54B	$21.37B
Operating Income	$4.66B	$8.52B	$13.74B	$7.95B	$13.31B	$13.91B	$11.99B	$4.02B
Interest Expense	—	—	$2.66B	$2.29B	$2.50B	$2.91B	$3.04B	$2.62B
Other Income / (Expense)	$112.00M	$99.00M	$88.00M	$169.00M	$182.00M	$206.00M	$124.00M	$4.00M
Income Before Taxes	$2.14B	$6.15B	$11.17B	$5.84B	$10.54B	$9.77B	$9.00B	$1.41B
Provision for Income Taxes	$408.00M	$1.56B	$2.81B	$1.51B	$2.55B	$2.57B	$2.37B	$2.00B
Net Income	$1.77B	$4.61B	$8.34B	$4.31B	$8.00B	$7.18B	$6.63B	-$594.00M
Basic EPS	$1.40	$3.67	$6.49	$3.29	$6.07	$5.48	$5.10	-$0.57
Diluted EPS	$1.39	$3.66	$6.47	$3.26	$6.02	$5.46	$5.08	-$0.57
Basic Shares Outstanding	1.27B	1.26B	1.28B	1.31B	1.32B	1.31B	1.30B	1.04B
Diluted Shares Outstanding	1.27B	1.26B	1.29B	1.32B	1.33B	1.31B	1.30B	1.04B

Analyst Estimates

Period	Consensus EPS	Low	High	Estimates	Revisions
Dec 2026	$7.46	$7.35	$7.65	12	↑1 ↓0
Dec 2027	$8.39	$8.20	$8.75	12	↑1 ↓0
Dec 2028	$9.39	$9.18	$9.75	6	↑1 ↓0
Dec 2029	$10.17	$10.17	$10.17	1	↑0 ↓0

Forward estimates are the sell-side consensus reported by Nasdaq, not a metir forecast.

Symbol: CVS
Type: Stock
Sector: Consumer Staples
Industry: Retail-Drug Stores and Proprietary Stores
Country: North America
Exchange: NYSE

CVS Health is a leading health solutions company simplifying health care one person, one family and one community at a time. As of March 31, 2026, the Company had approximately 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics and a leading pharmacy benefits manager with approximately 88 million plan members. The Company also serves an estimated more than 37 million people through a broad range of health insurance products and related services. The Company's integrated model uses personalized, technology driven services to connect people to simply better health, increasing access to quality care, delivering better outcomes, and lowering overall costs.

Key Issues

Bullish view

CVS delivered a 37.97% earnings surprise and a 5.91% revenue surprise for the quarter ended June 2026, while RTTNews reported that quarterly profit increased year over year. That performance supports the view that the company can continue exceeding estimates.

Bearish view

One quarterly beat does not establish a durable trend, particularly because the supplied evidence gives no detail on the sources or quality of the profit increase. Investors still need to assess whether the improvement can persist after the earnings release.

Analyst Consensus

See all

Buy

23 analysts

$100

Current

—

Low

$114

Average

—

High

Average target implies +13.44% versus the current price.

Earnings History

BeatMissNo estimate

CVS Health Corporation

Analyst Estimates

Peers